Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?

导出 LinkOut

翻译打印收藏纠错

第一作者： Gokhan,Ucar

第一单位： Medical Oncology, Health of Science Ankara City Hospital, Ankara, TUR.

作者： Gokhan,Ucar ^[1] ; Yusuf,Acikgoz ^[1] ; Yakup,Ergun ^[1] ; Oznur,Bal ^[1] ; Mesut,Yilmaz ^[2] ; Serdar,Karakaya ^[3] ; Nadiye,Akdeniz ^[4] ; Osman,Kostek ^[5] ; Ozlem,Aydin Isak ^[6] ; Gorkem,Yazici Sener ^[7] ; Merve,Dirikoc ^[1] ; Selin,Aktürk Esen ^[1] ; Mutlu,Dogan ^[3] ; Dogan,Uncu ^[1]

作者单位： Medical Oncology, Health of Science Ankara City Hospital, Ankara, TUR. ^[1] Medical Oncology, Bakırkoy Sadi Konuk Training and Research Hospital, Istanbul, TUR. ^[2] Medical Oncology, Health of Science Abdurrahman Yurtaslan Training and Research Hospital, Ankara, TUR. ^[3] Medical Oncology, Dicle University Medical Faculty, Diyarbakır, TUR. ^[4] Medical Oncology, Trakya University Medical Faculty, Edirne, TUR. ^[5] Medical Oncology, Health of Science Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, TUR. ^[6] Internal Medicine, Gazi University Medical Faculty, Ankara, TUR. ^[7]

关键词 metastasis nivolumab pazopanib renal cell carcinoma sunitinib

DOI 10.7759/cureus.10525

PMID 33094066

发布时间 2020-10-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cureus

2020年12卷9期

e10525页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?

Cureus

相似文献

Cureus

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?

Cureus

相似文献

Cureus

相关期刊

检索历史清除